Literature DB >> 7807020

Protective and nonprotective monoclonal antibodies to Cryptococcus neoformans originating from one B cell.

J Mukherjee1, G Nussbaum, M D Scharff, A Casadevall.   

Abstract

Two immunoglobulin M monoclonal antibodies (mAbs) derived from the same B cell recognize different epitopes on the capsular polysaccharide of the pathogenic yeast, Cryptococcus neoformans. Their respective epitopes are located in spatially distinct regions of the capsule. Passive administration of one mAb prolonged survival whereas the other mAb did not. The results indicate that specificity is an important determinant of antibody efficacy against C. neoformans and that somatic mutations occurring during the antibody response can affect the protective efficacy of antibodies to C. neoformans.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7807020      PMCID: PMC2191853          DOI: 10.1084/jem.181.1.405

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  24 in total

Review 1.  The role of somatic hypermutation in the generation of antibody diversity.

Authors:  D L French; R Laskov; M D Scharff
Journal:  Science       Date:  1989-06-09       Impact factor: 47.728

2.  Somatic evolution of variable region structures during an immune response.

Authors:  L Wysocki; T Manser; M L Gefter
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

3.  Structure and antigenic activity of the capsular polysaccharide of Cryptococcus neoformans serotype A.

Authors:  R Cherniak; E Reiss; M E Slodki; R D Plattner; S O Blumer
Journal:  Mol Immunol       Date:  1980-08       Impact factor: 4.407

4.  Passive immunization in murine cryptococcosis.

Authors:  J R Graybill; M Hague; D J Drutz
Journal:  Sabouraudia       Date:  1981-12

5.  Role of IgG and complement component C5 in the initial course of experimental cryptococcosis.

Authors:  F Dromer; C Perronne; J Barge; J L Vilde; P Yeni
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

6.  Opsonization of Cryptococcus neoformans by a family of isotype-switch variant antibodies specific for the capsular polysaccharide.

Authors:  A M Schlageter; T R Kozel
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

7.  Opsonization of encapsulated Cryptococcus neoformans by specific anticapsular antibody.

Authors:  T R Kozel; J L Follette
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

8.  The mouse antibody response to infection with Cryptococcus neoformans: VH and VL usage in polysaccharide binding antibodies.

Authors:  A Casadevall; M D Scharff
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

9.  The importance of the location of antibody binding on the M6 protein for opsonization and phagocytosis of group A M6 streptococci.

Authors:  K F Jones; V A Fischetti
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

10.  Inter- and intraclonal diversity in the antibody response to influenza hemagglutinin.

Authors:  S H Clarke; K Huppi; D Ruezinsky; L Staudt; W Gerhard; M Weigert
Journal:  J Exp Med       Date:  1985-04-01       Impact factor: 14.307

View more
  76 in total

1.  Combinatorial library cloning of human antibodies to Streptococcus pneumoniae capsular polysaccharides: variable region primary structures and evidence for somatic mutation of Fab fragments specific for capsular serotypes 6B, 14, and 23F.

Authors:  A H Lucas; K D Moulton; V R Tang; D C Reason
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

2.  Variants of a Cryptococcus neoformans strain elicit different inflammatory responses in mice.

Authors:  L C Chen; A Casadevall
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

3.  Basic problems of serological laboratory diagnosis.

Authors:  W Fierz
Journal:  Mol Biotechnol       Date:  1999-12-01       Impact factor: 2.695

Review 4.  Antibody-mediated immunity against intracellular pathogens: two-dimensional thinking comes full circle.

Authors:  Arturo Casadevall
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

5.  Ab binding alters gene expression in Cryptococcus neoformans and directly modulates fungal metabolism.

Authors:  Erin E McClelland; André M Nicola; Rafael Prados-Rosales; Arturo Casadevall
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

6.  Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations.

Authors:  Leonardo Nimrichter; Susana Frases; Leonardo P Cinelli; Nathan B Viana; Antonio Nakouzi; Luiz R Travassos; Arturo Casadevall; Marcio L Rodrigues
Journal:  Eukaryot Cell       Date:  2007-06-15

7.  Immunogenicity and efficacy of Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan peptide mimotope-protein conjugates in human immunoglobulin transgenic mice.

Authors:  Robert W Maitta; Kausik Datta; Andrew Lees; Shelley Sims Belouski; Liise-anne Pirofski
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Variable efficacy of passive antibody administration against diverse Cryptococcus neoformans strains.

Authors:  J Mukherjee; M D Scharff; A Casadevall
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

9.  The monoclonal antibody against the major diagnostic antigen of Paracoccidioides brasiliensis mediates immune protection in infected BALB/c mice challenged intratracheally with the fungus.

Authors:  R Buissa-Filho; R Puccia; A F Marques; F A Pinto; J E Muñoz; J D Nosanchuk; L R Travassos; C P Taborda
Journal:  Infect Immun       Date:  2008-05-05       Impact factor: 3.441

10.  A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection.

Authors:  Y Han; R P Morrison; J E Cutler
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.